ECM
ACLX

Everence Capital Management’s Arcellx ACLX Stock Holding History

Everence Capital Management’s Portfolio ACLX Stock Details ACLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$217K Buy
+1,888
New +$167K 0.01% 719

Other funds holding ACLX

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Everence Capital Management's ACLX Position: Q1 2026 in Review

Everence Capital Management opened a new position in Arcellx (ACLX) in Q1 2026: 1,888 shares worth $217K. The stake represents 0.01% of the portfolio and ranks #719 among its holdings.

239 funds tracked by Wall St. Rank hold ACLX as of Q1 2026.

  • Everence Capital Management held 1,888 shares of Arcellx worth $217K as of Q1 2026.
  • Arcellx was a new Everence Capital Management position in Q1 2026.
  • Arcellx made up 0.01% of Everence Capital Management's portfolio in Q1 2026, its #719 holding.
  • 239 funds tracked by Wall St. Rank held Arcellx as of Q1 2026.

Based on Everence Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.